START UPS

Most of the money the Israeli data storage management company is raising at a valuation of $30 billion will go to investors and employees, “Globes” has learned.

The Israeli startup will provide Elbit Systems with electrical-hybrid motors that are suitable for tactical drones.

Shahar Papini is a co-founder of Attestable, a developer of technology to verify the authenticity of data in the AI era.

The funds will be used to speed up deployment of DeepSky, an AI-native weather satellite constellation.

The AI-driven contextual data security has achieved rapid market penetration with tier-1 global customers.

Israeli venture capitalist Eden Shochat tells the ‘science fiction’ story and inspired bet behind the Israeli startup that has become Apple’s second biggest-ever acquisition.

With dollar capital and sales worth fewer shekels for paying salaries, companies face difficult manpower choices.

Overall in 2025, Israeli privately-held tech companies raised $10.7 billion, according to IVC-LeumiTech, up from $9.58 billion in 2024 and $6.9 billion in 2023 but well below $15 billion raised in 2022, and the record $25.6 billion raised in 2021.

Aviad Maizels has pulled off the unique trick of selling two companies to Apple but this time with much greater financial success.

The Israeli company claims the system is able to save between 15% and 35% of total cloud costs.

Prof. Matan Gavish has raised a huge seed round to challenge Adobe’s 30 year old PDFs, with a more sophisticated digital format.

The Israeli company has developed an implant to protect healthy tissue from radiation damage.

The company has developed a security platform that identifies and thwarts phishing attacks and account takeovers at an extremely early stage.

The Israeli company has developed a comprehensive cloud security platform using a unique approach, powering traditional CNAPP capabilities with runtime context.

Market sources estimate the acquisition price for the dropship automation company at $150-200 million.

The funds include a secondary round of up to $50 million after the Israeli company, which protects critical infrastructures, has delayed a planned IPO.

2025 was highly successful for defense startups in Israel, which won orders worth NIS 1.08 billion, about 25% of which came from foreign customers.

Datarails has developed a software for Excel users, which it claims, transforms the CFO’s office.

The US-Israel fund has closed the first $100 million and will invest in companies developing critical technologies for infrastructures in the US and its allies.

As part of the agreement, Kela will receive exclusive rights to sell, integrate and deploy Starling's Pathfinder X autonomous unmanned aerial vehicle (UAV) system in the IDF.

The fintech company is not publishing the number of employees included in the layoff process, but according to industry estimates, it is more than 100 employees.

At 64, in the midst of giving evidence in the Netanyahu corruption trial, former Walla! CEO Ilan Yeshua cofounded Seraphic Security, acquired this week by Crowdstrike.

Based in Miami and with a development center in Tel Aviv, Cast AI develops software that manages the use of graphics processors (GPUs).

Novee provides continuous, AI-driven penetration testing, simulating the sophisticated tactics of real-world hackers.

The Israeli data storage management company is raising $1 billion at a valuation of $25 billion, together with a secondary round in the hundreds of millions of dollars.

A panel from Lipa & Co., Greenberg Traurig and Valley Bank examined the expansion of defense-tech companies into the US, exploring risks and focusing on opportunities and strategic considerations.

Over a dozen pharma and biotech customers already use Converge's solutions for target discovery, antibody design, and protein manufacturing optimization.

Seraphic Security is engaged in browser security and has developed a complementary product to Crowdstrike's endpoint protection system.

Following media reports on an acquisition of the Israeli AI company by Nvidia, AI21 Labs insists the reports are incorrect.

The main investors in Arkin Bio Ventures III together with Arkin Capital are Israeli institutional investors including Phoenix Finance, Clal Insurance, and Amitim pension fund.